Nonoperating Income (Expense) in USD of BIO-TECHNE Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BIO-TECHNE Corp quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2010 to Q3 2025.
  • BIO-TECHNE Corp Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $333K, a 81% increase year-over-year.
  • BIO-TECHNE Corp Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$3.64M, a 74.9% increase year-over-year.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2025 was -$3.79M, a 81.9% increase from 2024.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2024 was -$21M, a 153% decline from 2023.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2023 was $39.7M, a 728% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3.64M $333K +$149K +81% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$3.79M $1M +$5.16M 01 Apr 2025 30 Jun 2025 10-K 22 Aug 2025
Q1 2025 -$8.96M -$434K +$5.48M +92.7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$14.4M -$4.54M +$74K +1.6% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 -$14.5M $184K +$6.49M 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$21M -$4.16M +$2.05M +32.9% 01 Apr 2024 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 -$23M -$5.91M -$5.9M -39327% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$17.1M -$4.62M -$3.16M -216% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025
Q3 2023 -$14M -$6.3M -$53.7M -113% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 $39.7M -$6.21M -$4.69M -308% 01 Apr 2023 30 Jun 2023 10-K 22 Aug 2025
Q1 2023 $44.4M -$15K +$21.7M +99.9% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 $22.7M -$1.46M -$25.3M -106% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 $48M $47.4M +$43.2M +1039% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $4.8M -$1.52M +$59.9M +97.5% 01 Apr 2022 30 Jun 2022 10-K 22 Aug 2024
Q1 2022 -$55.2M -$21.7M +$1.6M +6.86% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 -$56.7M $23.8M +$18.5M +344% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 -$75.2M $4.16M +$13.9M 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$89.1M -$61.5M -$83.7M -377% 01 Apr 2021 30 Jun 2021 10-K 23 Aug 2023
Q1 2021 -$5.44M -$23.3M -$22.3M -2299% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $16.9M $5.37M -$108M -95.3% 01 Oct 2020 31 Dec 2020 10-Q 07 Feb 2022
Q3 2020 $125M -$9.75M +$5.77M +37.2% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $119M $22.2M +$42.7M 01 Apr 2020 30 Jun 2020 10-K 24 Aug 2022
Q1 2020 $76.4M -$970K -$6.76M -117% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $83.1M $113M +$125M 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021
Q3 2019 -$42M -$15.5M -$7.34M -89.8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$34.7M -$20.5M -$33.8M -253% 01 Apr 2019 30 Jun 2019 10-K 25 Aug 2021
Q1 2019 -$869K $5.79M +$23.9M 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$24.8M -$11.8M -$9.42M -390% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q3 2018 -$15.3M -$8.18M -$5.11M -167% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 -$10.2M $13.4M +$15.6M 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2020
Q1 2018 -$25.8M -$18.1M -$15.7M -667% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q4 2017 -$10M -$2.42M +$276K +10.2% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 -$10.3M -$3.06M -$1.69M -123% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 -$8.62M -$2.2M +$44K +1.96% 01 Apr 2017 30 Jun 2017 10-K/A 06 Nov 2019
Q1 2017 -$8.67M -$2.36M -$1.32M -128% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$7.34M -$2.69M -$2.04M -314% 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018
Q3 2016 -$5.3M -$1.37M -$2.19M -268% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$3.11M -$2.24M -$2.68M -608% 01 Apr 2016 30 Jun 2016 10-K 27 Aug 2018
Q1 2016 -$429K -$1.04M -$370K -55.5% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$59K -$651K -$8.63M -108% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 $8.58M $818K +$1.44M 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $7.14M $441K -$164K -27.1% 01 Apr 2015 30 Jun 2015 10-K 07 Sep 2017
Q1 2015 $7.3M -$667K -$967K -322% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $8.27M $7.98M +$7.51M +1584% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q3 2014 $761K -$618K -$881K -335% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $1.64M $605K -$343K -36.2% 01 Apr 2014 30 Jun 2014 10-K 29 Aug 2016
Q1 2014 $1.99M $300K -$220K -42.3% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $2.21M $474K -$68K -12.5% 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015
Q3 2013 $2.27M $263K +$80K +43.7% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $2.19M $948K +$1.55M 01 Apr 2013 30 Jun 2013 10-K 31 Aug 2015
Q1 2013 $644K $520K +$3.68M 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 -$3.03M $542K +$351K +184% 01 Oct 2012 31 Dec 2012 10-Q 04 Feb 2014
Q3 2012 -$3.38M $183K +$630K 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 -$4.01M -$601K -$969K -263% 01 Apr 2012 30 Jun 2012 10-K 29 Aug 2014
Q1 2012 -$3.05M -$3.16M -$3.8M -589% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $758K $191K -$131K -40.7% 01 Oct 2011 31 Dec 2011 10-Q 11 Feb 2013
Q3 2011 $889K -$447K -$1.04M -176% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $1.93M $368K 01 Apr 2011 30 Jun 2011 10-K 29 Aug 2013
Q1 2011 $646K +$855K 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q4 2010 $322K 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012
Q3 2010 $590K 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011
Q1 2010 -$209K 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011

BIO-TECHNE Corp Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$3.79M +$17.2M +81.9% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025
2024 -$21M -$60.7M -153% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025
2023 $39.7M +$34.9M +728% 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025
2022 $4.8M +$93.9M 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024
2021 -$89.1M -$208M -175% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023
2020 $119M +$154M 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022
2019 -$34.7M -$24.5M -239% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021
2018 -$10.2M -$1.6M -18.6% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020
2017 -$8.62M -$5.51M -177% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019
2016 -$3.11M -$10.3M -144% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018
2015 $7.14M +$5.5M +335% 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017
2014 $1.64M -$551K -25.1% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016
2013 $2.19M +$6.21M 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015
2012 -$4.01M -$5.94M -308% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2014
2011 $1.93M +$1.81M +1532% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013
2010 $118K 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.